drugset / Trial / NCT06277609

A Trial Investigating Lu AF28996 in Healthy Adult Participants

NCT06277609

Phase 1 Completed 22 enrolled H. Lundbeck A/S
Non-randomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to investigate repeated doses of Lu AF28996 in healthy participants and co-administered with two other compounds, and in a separate cohort following co-administration with antibiotics, to see how well the doses are tolerated and what the body does to the drug after administering it.

Timeline

Start
2024-02-27
Primary completion
2024-05-19
Completion
2024-05-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin/clavulanic acid Unknown
Subject Aspirin Small molecule
Subject Lu AF28996 Unknown
Subject Mefenamic acid Small molecule

Indications

No indication recorded.